Phase 3 Readout~month
Phase 3 Topline: A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121/TEZ/D-IVA Combina
- Indication
- Cystic Fibrosis
Other upcoming events for VRTX
Patent ExpiryPatent/Exclusivity Expiry: APLENZIN
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121/TEZ/D-IVA Combina
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Open-label Study Evaluating the Long-term Safety and Effectiveness of Suzetrigine in Subj
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Open-label Study Evaluating the Long-term Safety and Effectiveness of Suzetrigine in Subj
Phase 3 ReadoutPhase 3 Topline: A Phase 3 Open-label Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Iv
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.